KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Preferred Stock Liabilities (2017 - 2018)

Historic Preferred Stock Liabilities for Twist Bioscience (TWST) over the last 2 years, with Q3 2018 value amounting to $290.5 million.

  • Twist Bioscience's Preferred Stock Liabilities rose 12717.77% to $290.5 million in Q3 2018 from the same period last year, while for Sep 2018 it was $290.5 million, marking a year-over-year increase of 12717.77%. This contributed to the annual value of $290.5 million for FY2018, which is 12717.77% up from last year.
  • Latest data reveals that Twist Bioscience reported Preferred Stock Liabilities of $290.5 million as of Q3 2018, which was up 12717.77% from $127.9 million recorded in Q3 2017.
  • In the past 5 years, Twist Bioscience's Preferred Stock Liabilities ranged from a high of $290.5 million in Q3 2018 and a low of $127.9 million during Q3 2017